Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.
GHDx Entry last modified on: May 12, 2022
Blood tests
Dataset Records for Blood tests
Displaying 151 - 200 of 1386
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign
GHDx Entry last modified on: Jun 17, 2021
A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled blood. Preprint
GHDx Entry last modified on: Mar 14, 2022
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
GHDx Entry last modified on: Jun 17, 2021
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jun 17, 2021
Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study
GHDx Entry last modified on: Mar 14, 2022
[Seroepidemiological surveillance of SARS-CoV-2 circulation in 41 municipalities in Honduras with no report of active cases, COVID-19, June 16-23, 2020]
Vigilancia seroepidemiológica de la circulación del SARS-CoV-2 en 41 municipios de Honduras sin reporte de casos activos, COVID-19, del 16- 23 junio 2020
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a University Hospital in Bogota, Colombia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India
GHDx Entry last modified on: Jun 17, 2021
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. Preprint
GHDx Entry last modified on: Mar 14, 2022
Is Karachi Knocking at Herd Immunity? A Possible Reason for Decline in SARS-CoV-2 Infections. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
High SARS-CoV-2 Seroprevalence in Children and Adults in the Austrian Ski Resort Ischgl. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study. Preprint
GHDx Entry last modified on: May 12, 2022
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Scientific literature:
Cross-sectional
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behavior measures: Results from the DETECTCoV-19 cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France. Preprint
GHDx Entry last modified on: Mar 14, 2022
Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
[Features of developing SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 epidemic in the Russian Federation]
ОСОБЕННОСТИ ФОРМИРОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ НАСЕЛЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ К НУКЛЕОКАПСИДУ SARS-CoV-2 В ПЕРВУЮ ВОЛНУ ЭПИДЕМИИ COVID-19
Sero-Epidemiological Survey and Profile of SARS-CoV-2 Infection in Cape Verde. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence evolution of SARS-CoV-2 infection in the Municipality of São Paulo, 2020 - 2021
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Mar 14, 2022
The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study. Preprint
GHDx Entry last modified on: May 12, 2022
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
GHDx Entry last modified on: Feb 10, 2022
Evidence for and level of herd immunity against SARS-CoV-2 infection: the ten-community study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Performance of rapid IgM-IgG combined antibody tests in the occupational surveillance of COVID-19 in Colombian enterprises
GHDx Entry last modified on: Mar 14, 2022
Trends of SARS-CoV-2 antibody prevalence in selected regions across Ghana. Preprint
GHDx Entry last modified on: May 12, 2022
Contrasting SARS-CoV-2 epidemics in Singapore: Cohort studies in migrant workers and the general population. Preprint
GHDx Entry last modified on: Mar 14, 2022
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint
GHDx Entry last modified on: Apr 8, 2022
COVID-Inconfidentes - SARS-CoV-2 seroprevalence in two Brazilian urban areas during the pandemic first wave: study protocol and initial results. Preprint
GHDx Entry last modified on: Mar 14, 2022
Canada - Daily Epidemiologic Summary of COVID-19 in Ontario 2020
Epidemiologic Summary COVID-19 in Ontario
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey. Preprint.
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
COVID Seroprevalence, Symptoms and Mortality During the First Wave of SARS-CoV-2 in Canada
GHDx Entry last modified on: May 12, 2022
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Subscribe